Posted in | News

Ceratech Releases E-Brochure Titled High-Performance Industrial Cement Solutions

Ceratech, a manufacturer of long-lasting concrete cements, has released an e-brochure titled “High performance Industrial Cement Solutions” in both digital and print format. The company provides an e-brochure covering Ceratech’s complete cement line, which have been formed mainly for chemical processing and severe industrial environments.

Construction using the high performance long-lasting cements

The Ceratech cements show high resistance to both corrosive materials and severe temperatures, when compared to traditional Portland cement.

Leo Kahl, Ceratech’s Marketing Vice President, said that the company is pleased that it has been receiving repeat orders with its FIREROK, ekkomaxx200 and KEMROK portfolios. Kahl stated that the fact that customers are repeatedly using its brands signifies the performance advantages and product quality of its products over conventional Portland cements.

The Ceratech’s KEMROK cement is developed particularly to resist corrosive chemicals, harmful acids and extreme temperatures. FIREROK cement is formulated with more resistance to increased temperatures when exposed to metal processing and other industrial processes. The ekkomaxx200 branded cements will offers resistance to corrosive materials and higher temperatures at reduced cost. Since the branded cements of Ceratech are developed with 5% renewable and 95% recycled materials in a carbon-free process, they exhibit comparably increased rate in sustainability scale than the traditional Portland cements.

Mark Wasilko, Executive Vice President of Ceratech, said that the company’s cement technology provides significantly high value by increasing the concrete lifecycle. Wasilko also added that the company is able to deliver highly cost-effective and increased durability industrial strength product with a range of environmental advantages.

Source: http://www.ceratechinc.com/

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Scanlon, Joel. (2019, February 22). Ceratech Releases E-Brochure Titled High-Performance Industrial Cement Solutions. AZoBuild. Retrieved on April 19, 2024 from https://www.azobuild.com/news.aspx?newsID=14613.

  • MLA

    Scanlon, Joel. "Ceratech Releases E-Brochure Titled High-Performance Industrial Cement Solutions". AZoBuild. 19 April 2024. <https://www.azobuild.com/news.aspx?newsID=14613>.

  • Chicago

    Scanlon, Joel. "Ceratech Releases E-Brochure Titled High-Performance Industrial Cement Solutions". AZoBuild. https://www.azobuild.com/news.aspx?newsID=14613. (accessed April 19, 2024).

  • Harvard

    Scanlon, Joel. 2019. Ceratech Releases E-Brochure Titled High-Performance Industrial Cement Solutions. AZoBuild, viewed 19 April 2024, https://www.azobuild.com/news.aspx?newsID=14613.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.